Thursday, May 29, 2014

The Motley Fool: Why Stryker Should Buy Smith & Nephew

The M&A wheel continues to turn in med-tech, spurred on in part by the reality that making money the old fashioned way ("earning it", for those too young to remember the John Houseman commercials) is getting harder and harder. The latest rumor, that Stryker (NYSE: SYK  ) was taking a look at Smith & Nephew (NYSE: SNN  ) , was not only confirmed by Stryker but goes to show the depth of consolidation in med-tech as maturing markets leave fewer and fewer opportunities for sub-scale players.

Read more here:
Why Stryker Should Buy Smith & Nephew

No comments: